Page last updated: 2024-12-07

ly 293558

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tezampanel: structure given in first source; an AMPA receptor antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID127894
CHEMBL ID14935
SCHEMBL ID1649338
MeSH IDM0219354

Synonyms (39)

Synonym
tezampanel
HY-75704
3-isoquinolinecarboxylic acid, decahydro-6-(2-(1h-tetrazol-5-yl)ethyl)-, (3s,4ar,6r,8ar)-
6-(2-(1h-tetrazol-5-yl)ethyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid
ted-isoquinoline-3-cooh
3-isoquinolinecarboxylic acid, decahydro-6-(2-(1h-tetrazol-5-yl)ethyl)-, (3s-(3alpha,4aalpha,6beta,8aalpha))-
ly 293558
decahydro-6-(2-(1h-tetrazol-5-yl)ethyl)-3-isoquinolinecarboxylic acid
ly293558
ngx-424
ly-293,558
ly-293558
CHEMBL14935 ,
(3s,4ar,6r,8ar)-6-[2-(2h-tetrazol-5-yl)ethyl]-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid
150131-78-5
bdbm86751
ga36s2o9c2 ,
tezampanel, anhydrous
154652-83-2
unii-ga36s2o9c2
tezampanel (anhydrous)
tezampanel [inn]
CS-0821
(3s,4ar,6r,8ar)-6-[2-(1h-1,2,3,4-tetrazol-5-yl)ethyl]-decahydroisoquinoline-3-carboxylic acid
gtpl4245
(3s,4as,6r,8as)-6-(2-(1h-tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid
3-isoquinolinecarboxylic acid, decahydro-6-(2-(1h-tetrazol-5-yl)ethyl)-, (3s,4as,6r,8as)-
tezampanel anhydrous
SCHEMBL1649338
NCGC00378884-01
(3s,4ar,6r,8ar)-6-(2-(1h-tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid
154652-83-2 (anhydrous)
ly215490
DB06354
ly 293558;ly293558;ly-293558
bdbm50494341
Q7708612
(3s,4ar,6r,8ar)-6-[2-(2h-1,2,3,4-tetrazol-5-yl)ethyl]-decahydroisoquinoline-3-carboxylic acid
AKOS040749636

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" The slightly reduced neuroprotective effect of the highest dosing regimen may be due to the respiratory problems seen with this dose."( The neuroprotective effects of the decahydroisoquinoline, LY 215490; a novel AMPA antagonist in focal ischaemia.
Gill, R; Lodge, D, 1994
)
0.29
" A thorough dose-response study using microdialysis in conscious rats indicated that low doses of ketamine (10, 20, and 30 mg/kg) increase glutamate outflow in the PFC, suggesting that at these doses ketamine may increase glutamatergic neurotransmission in the PFC at non-NMDA glutamate receptors."( Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.
Adams, B; Daly, D; Moghaddam, B; Verma, A, 1997
)
0.3
" Administration of morphine, DPDPE, or U50,488H three times daily for 3 days according to an escalating dosing schedule resulted in analgesic tolerance as indicated by an increase in analgesic ED50 values using the tail-flick test in mice."( The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
Inturrisi, CE; Kao, B; Kest, B; McLemore, G, 1997
)
0.3
" There was a trend toward a dose-response effect of LY293558 on the area in which pinprick evoked pain after intradermal capsaicin, which did not reach statistical significance."( AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans.
Caruso, R; Chappell, AS; Gracely, RH; Hostetter, MP; Lee, G; Max, MB; Sang, CN; Schoepp, DD; Whitcup, S, 1998
)
0.3
" Initial dosing commenced 30 min prior to the 2-min 'pre-conditioning' ischaemia."( NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus.
Bond, A; Hicks, CA; Lodge, D; O'Neill, MJ; Ward, MA, 1999
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (35)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glutamate receptor ionotropic, NMDA 2DHomo sapiens (human)IC50 (µMol)12.10000.00401.73519.8000AID143099
Glutamate receptor ionotropic, NMDA 3BHomo sapiens (human)IC50 (µMol)12.10000.00401.65799.8000AID143099
Glutamate receptor 1Rattus norvegicus (Norway rat)IC50 (µMol)3.58790.00011.617910.0000AID31462; AID31463; AID92210; AID92211; AID92346; AID92348; AID92370; AID92371; AID92372; AID92509
Glutamate receptor 2Rattus norvegicus (Norway rat)IC50 (µMol)3.58790.00011.700010.0000AID31462; AID31463; AID92210; AID92211; AID92346; AID92348; AID92370; AID92371; AID92372; AID92509
Glutamate receptor 3Rattus norvegicus (Norway rat)IC50 (µMol)3.58790.00011.700010.0000AID31462; AID31463; AID92210; AID92211; AID92346; AID92348; AID92370; AID92371; AID92372; AID92509
Glutamate receptor 4Rattus norvegicus (Norway rat)IC50 (µMol)3.58790.00011.700010.0000AID31462; AID31463; AID92210; AID92211; AID92346; AID92348; AID92370; AID92371; AID92372; AID92509
Glutamate receptor ionotropic, kainate 1Rattus norvegicus (Norway rat)IC50 (µMol)107.60380.00700.98217.0000AID93559; AID93562; AID93576; AID93577; AID95026
Adenosine receptor A1Rattus norvegicus (Norway rat)Ki100.00000.00011.20929.9700AID239193
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)IC50 (µMol)21.97690.00071.600310.0000AID143295; AID143306; AID143317; AID144469; AID144599; AID144617; AID144618; AID144764; AID145268; AID496836; AID73794
Glutamate receptor ionotropic, kainate 1Homo sapiens (human)IC50 (µMol)123.75000.07702.64425.0000AID726083; AID91457
Glutamate receptor ionotropic, kainate 1Homo sapiens (human)Ki4.18670.00071.75084.8000AID1054526; AID239192; AID496857
Glutamate receptor ionotropic, kainate 2Rattus norvegicus (Norway rat)IC50 (µMol)107.60380.00701.01327.0000AID93559; AID93562; AID93576; AID93577; AID95026
Glutamate receptor 1Homo sapiens (human)IC50 (µMol)3.07500.01901.70836.5100AID31732; AID92801
Glutamate receptor 1Homo sapiens (human)Ki9.20000.01472.50379.2000AID496853; AID92950
Glutamate receptor 2Homo sapiens (human)IC50 (µMol)3.07500.01901.64035.5000AID31732; AID92801
Glutamate receptor 2Homo sapiens (human)Ki2.90250.01681.27725.0000AID1054527; AID239233; AID496854; AID92961
Glutamate receptor 3Homo sapiens (human)IC50 (µMol)3.07500.01901.13424.8000AID31732; AID92801
Glutamate receptor 3Homo sapiens (human)Ki32.00000.02060.53222.2000AID496855; AID93101
Glutamate receptor ionotropic, kainate 3Rattus norvegicus (Norway rat)IC50 (µMol)107.60380.00701.01327.0000AID93559; AID93562; AID93576; AID93577; AID95026
Glutamate receptor 4Homo sapiens (human)IC50 (µMol)3.07500.01901.22234.8000AID31732; AID92801
Glutamate receptor 4Homo sapiens (human)Ki50.25000.04001.23358.8500AID496856; AID93110
D(2) dopamine receptorRattus norvegicus (Norway rat)Ki100.00000.00000.437510.0000AID239193
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)IC50 (µMol)21.97690.00071.630610.0000AID143295; AID143306; AID143317; AID144469; AID144599; AID144617; AID144618; AID144764; AID145268; AID496836; AID73794
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)IC50 (µMol)21.97690.00061.525710.0000AID143295; AID143306; AID143317; AID144469; AID144599; AID144617; AID144618; AID144764; AID145268; AID496836; AID73794
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)IC50 (µMol)21.97690.00071.747210.0000AID143295; AID143306; AID143317; AID144469; AID144599; AID144617; AID144618; AID144764; AID145268; AID496836; AID73794
Glutamate receptor ionotropic, kainate 4Rattus norvegicus (Norway rat)IC50 (µMol)107.60380.00701.01327.0000AID93559; AID93562; AID93576; AID93577; AID95026
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)IC50 (µMol)12.10000.00101.88779.8000AID143099
Glutamate receptor ionotropic, NMDA 2AHomo sapiens (human)IC50 (µMol)12.10000.00101.99589.8000AID143099
Glutamate receptor ionotropic, kainate 2Homo sapiens (human)IC50 (µMol)247.00000.07700.07700.0770AID91457
Glutamate receptor ionotropic, kainate 2Homo sapiens (human)Ki100.00000.00120.33441.1060AID239193; AID496858; AID93403; AID93404
Glutamate receptor ionotropic, kainate 3Homo sapiens (human)IC50 (µMol)247.00000.07702.03854.0000AID91457
Glutamate receptor ionotropic, kainate 3Homo sapiens (human)Ki100.00000.01000.39950.7890AID496859
Glutamate receptor ionotropic, NMDA 2BHomo sapiens (human)IC50 (µMol)12.10000.00401.33259.8000AID143099
Glutamate receptor ionotropic, NMDA 2CHomo sapiens (human)IC50 (µMol)12.10000.00401.86339.8000AID143099
Glutamate receptor ionotropic, kainate 4Homo sapiens (human)IC50 (µMol)247.00000.07700.07700.0770AID91457
Glutamate receptor ionotropic, kainate 5Homo sapiens (human)IC50 (µMol)247.00000.07700.07700.0770AID91457
Sigma non-opioid intracellular receptor 1Cavia porcellus (domestic guinea pig)Ki4.20000.00000.338510.0000AID1054526
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)IC50 (µMol)21.97690.00071.741110.0000AID143295; AID143306; AID143317; AID144469; AID144599; AID144617; AID144618; AID144764; AID145268; AID496836; AID73794
Glutamate receptor ionotropic, kainate 5Rattus norvegicus (Norway rat)IC50 (µMol)107.60380.00701.01327.0000AID93559; AID93562; AID93576; AID93577; AID95026
Glutamate receptor ionotropic, NMDA 3AHomo sapiens (human)IC50 (µMol)12.10000.00401.65799.8000AID143099
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)IC50 (µMol)21.97690.00071.741110.0000AID143295; AID143306; AID143317; AID144469; AID144599; AID144617; AID144618; AID144764; AID145268; AID496836; AID73794
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)IC50 (µMol)21.97690.00071.741110.0000AID143295; AID143306; AID143317; AID144469; AID144599; AID144617; AID144618; AID144764; AID145268; AID496836; AID73794
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glutamate receptor ionotropic, kainate 1Homo sapiens (human)Kb0.20000.00800.40301.0000AID496857
Glutamate receptor 1Homo sapiens (human)Kb1.00000.16600.42201.0000AID496853
Glutamate receptor 2Homo sapiens (human)Kb0.70000.16600.34400.7000AID496854
Glutamate receptor 3Homo sapiens (human)Kb1.00001.00001.00001.0000AID496855
Glutamate receptor 4Homo sapiens (human)Kb17.00000.10200.10200.1020AID496856
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (110)

Processvia Protein(s)Taxonomy
startle responseGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
brain developmentGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
adult locomotory behaviorGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
calcium-mediated signalingGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
regulation of synaptic plasticityGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
regulation of neuronal synaptic plasticityGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
regulation of sensory perception of painGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
calcium ion transmembrane import into cytosolGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
excitatory chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
regulation of monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
cellular response to L-glutamateGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
positive regulation of excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
long-term synaptic potentiationGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
protein insertion into membraneGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
regulation of calcium ion transportGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
calcium ion transmembrane transportGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
nervous system developmentGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
central nervous system developmentGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
calcium-mediated signalingGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
regulation of receptor recyclingGlutamate receptor 1Homo sapiens (human)
signal transductionGlutamate receptor 1Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor 1Homo sapiens (human)
synapse assemblyGlutamate receptor 1Homo sapiens (human)
long-term memoryGlutamate receptor 1Homo sapiens (human)
response to xenobiotic stimulusGlutamate receptor 1Homo sapiens (human)
response to lithium ionGlutamate receptor 1Homo sapiens (human)
positive regulation of gene expressionGlutamate receptor 1Homo sapiens (human)
neuronal action potentialGlutamate receptor 1Homo sapiens (human)
calcium-mediated signalingGlutamate receptor 1Homo sapiens (human)
spinal cord developmentGlutamate receptor 1Homo sapiens (human)
cerebral cortex developmentGlutamate receptor 1Homo sapiens (human)
receptor internalizationGlutamate receptor 1Homo sapiens (human)
response to estradiolGlutamate receptor 1Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor 1Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor 1Homo sapiens (human)
response to cocaineGlutamate receptor 1Homo sapiens (human)
positive regulation of membrane potentialGlutamate receptor 1Homo sapiens (human)
response to arsenic-containing substanceGlutamate receptor 1Homo sapiens (human)
response to electrical stimulusGlutamate receptor 1Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor 1Homo sapiens (human)
long-term synaptic potentiationGlutamate receptor 1Homo sapiens (human)
long-term synaptic depressionGlutamate receptor 1Homo sapiens (human)
response to fungicideGlutamate receptor 1Homo sapiens (human)
cellular response to amino acid stimulusGlutamate receptor 1Homo sapiens (human)
cellular response to ammonium ionGlutamate receptor 1Homo sapiens (human)
cellular response to dsRNAGlutamate receptor 1Homo sapiens (human)
cellular response to peptide hormone stimulusGlutamate receptor 1Homo sapiens (human)
cellular response to amine stimulusGlutamate receptor 1Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor 1Homo sapiens (human)
regulation of postsynaptic cytosolic calcium ion concentrationGlutamate receptor 1Homo sapiens (human)
cellular response to brain-derived neurotrophic factor stimulusGlutamate receptor 1Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor 1Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor 1Homo sapiens (human)
signal transductionGlutamate receptor 2Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor 2Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor 2Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor 2Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor 2Homo sapiens (human)
monoatomic cation transmembrane transportGlutamate receptor 2Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor 2Homo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor 3Homo sapiens (human)
calcium-mediated signalingGlutamate receptor 3Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor 3Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor 3Homo sapiens (human)
protein homotetramerizationGlutamate receptor 3Homo sapiens (human)
protein heterotetramerizationGlutamate receptor 3Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor 3Homo sapiens (human)
long-term synaptic potentiationGlutamate receptor 3Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor 3Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor 3Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor 3Homo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor 4Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor 4Homo sapiens (human)
negative regulation of smooth muscle cell apoptotic processGlutamate receptor 4Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor 4Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor 4Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor 4Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor 4Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor 4Homo sapiens (human)
cellular response to amyloid-betaGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
monoatomic cation transportGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
brain developmentGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
visual learningGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
positive regulation of calcium ion transport into cytosolGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
propylene metabolic processGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calcium-mediated signalingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
regulation of membrane potentialGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
response to ethanolGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
regulation of synaptic plasticityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
regulation of neuronal synaptic plasticityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
protein heterotetramerizationGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calcium ion homeostasisGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calcium ion transmembrane import into cytosolGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
excitatory chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
positive regulation of reactive oxygen species biosynthetic processGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
regulation of monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
response to glycineGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
positive regulation of excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
cellular response to amyloid-betaGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
startle responseGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
response to amphetamineGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
brain developmentGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
learning or memoryGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
memoryGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
visual learningGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
response to xenobiotic stimulusGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
response to woundingGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
sensory perception of painGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
calcium-mediated signalingGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
neurogenesisGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
protein catabolic processGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
sleepGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
directional locomotionGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
negative regulation of protein catabolic processGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
dopamine metabolic processGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
serotonin metabolic processGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
positive regulation of apoptotic processGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
response to ethanolGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
regulation of synaptic plasticityGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
regulation of neuronal synaptic plasticityGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
activation of cysteine-type endopeptidase activityGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
calcium ion transmembrane import into cytosolGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
excitatory chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
protein localization to postsynaptic membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
regulation of monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
positive regulation of excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
long-term synaptic potentiationGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
behavioral fear responseGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
intracellular calcium ion homeostasisGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
neuronal action potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
receptor clusteringGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
negative regulation of neuron apoptotic processGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
positive regulation of neuron apoptotic processGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
regulation of JNK cascadeGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
regulation of long-term neuronal synaptic plasticityGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
regulation of short-term neuronal synaptic plasticityGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
positive regulation of synaptic transmissionGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
neuron apoptotic processGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
negative regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
inhibitory postsynaptic potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
modulation of excitatory postsynaptic potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
detection of cold stimulus involved in thermoceptionGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
regulation of membrane potentialGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
regulation of membrane potentialGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
negative regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
brain developmentGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
learning or memoryGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
calcium-mediated signalingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
response to ethanolGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
regulation of synaptic plasticityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
regulation of neuronal synaptic plasticityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
protein heterotetramerizationGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
calcium ion transmembrane import into cytosolGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
excitatory chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
negative regulation of dendritic spine maintenanceGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
regulation of monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
positive regulation of excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
positive regulation of cysteine-type endopeptidase activityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
long-term synaptic potentiationGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
brain developmentGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
response to woundingGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
calcium-mediated signalingGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
directional locomotionGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
negative regulation of protein catabolic processGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
regulation of synaptic plasticityGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
regulation of neuronal synaptic plasticityGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
neuromuscular process controlling balanceGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
calcium ion transmembrane import into cytosolGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
excitatory chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
protein localization to postsynaptic membraneGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
regulation of monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
positive regulation of excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
long-term synaptic potentiationGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
regulation of synaptic vesicle fusion to presynaptic active zone membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
calcium ion transportGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
dendrite developmentGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
response to ethanolGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
rhythmic processGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
prepulse inhibitionGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
negative regulation of dendritic spine developmentGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
calcium ion transmembrane transportGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
presynaptic modulation of chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (43)

Processvia Protein(s)Taxonomy
glutamate-gated receptor activityGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
protein bindingGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
glutamate bindingGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
voltage-gated monoatomic cation channel activityGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
calcium channel activityGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
monoatomic cation channel activityGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
glycine bindingGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
neurotransmitter receptor activityGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
glutamate receptor activityGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
glutamate-gated receptor activityGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
kainate selective glutamate receptor activityGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
amyloid-beta bindingGlutamate receptor 1Homo sapiens (human)
G-protein alpha-subunit bindingGlutamate receptor 1Homo sapiens (human)
AMPA glutamate receptor activityGlutamate receptor 1Homo sapiens (human)
protein bindingGlutamate receptor 1Homo sapiens (human)
glutamate receptor activityGlutamate receptor 1Homo sapiens (human)
adenylate cyclase bindingGlutamate receptor 1Homo sapiens (human)
immunoglobulin bindingGlutamate receptor 1Homo sapiens (human)
protein kinase bindingGlutamate receptor 1Homo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor 1Homo sapiens (human)
PDZ domain bindingGlutamate receptor 1Homo sapiens (human)
small GTPase bindingGlutamate receptor 1Homo sapiens (human)
myosin V bindingGlutamate receptor 1Homo sapiens (human)
G-protein beta-subunit bindingGlutamate receptor 1Homo sapiens (human)
beta-2 adrenergic receptor bindingGlutamate receptor 1Homo sapiens (human)
glutamate receptor bindingGlutamate receptor 1Homo sapiens (human)
identical protein bindingGlutamate receptor 1Homo sapiens (human)
protein kinase A bindingGlutamate receptor 1Homo sapiens (human)
scaffold protein bindingGlutamate receptor 1Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor 1Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor 1Homo sapiens (human)
neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentrationGlutamate receptor 1Homo sapiens (human)
AMPA glutamate receptor activityGlutamate receptor 2Homo sapiens (human)
amyloid-beta bindingGlutamate receptor 2Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor 2Homo sapiens (human)
AMPA glutamate receptor activityGlutamate receptor 2Homo sapiens (human)
protein bindingGlutamate receptor 2Homo sapiens (human)
ligand-gated monoatomic cation channel activityGlutamate receptor 2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor 2Homo sapiens (human)
amyloid-beta bindingGlutamate receptor 3Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor 3Homo sapiens (human)
AMPA glutamate receptor activityGlutamate receptor 3Homo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor 3Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor 3Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor 3Homo sapiens (human)
amyloid-beta bindingGlutamate receptor 4Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor 4Homo sapiens (human)
AMPA glutamate receptor activityGlutamate receptor 4Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor 4Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor 4Homo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calcium channel activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
amyloid-beta bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calcium ion bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
protein bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calmodulin bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
glycine bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
glutamate bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
protein-containing complex bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
signaling receptor activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
ligand-gated monoatomic ion channel activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
amyloid-beta bindingGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
protein bindingGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
zinc ion bindingGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
SNARE bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
extracellularly glutamate-gated ion channel activityGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
kainate selective glutamate receptor activityGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
PDZ domain bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
ubiquitin conjugating enzyme bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
ubiquitin protein ligase bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
identical protein bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
scaffold protein bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
adenylate cyclase inhibiting G protein-coupled glutamate receptor activityGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
glutamate receptor activityGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
kainate selective glutamate receptor activityGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
amyloid-beta bindingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
protein bindingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
zinc ion bindingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
glycine bindingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
glutamate bindingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
protein bindingGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
kainate selective glutamate receptor activityGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
kainate selective glutamate receptor activityGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
calcium channel activityGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
protein bindingGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
glycine bindingGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
identical protein bindingGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
protein phosphatase 2A bindingGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
glutamate receptor activityGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (59)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
postsynaptic membraneGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
presynaptic active zone membraneGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
hippocampal mossy fiber to CA3 synapseGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
glutamatergic synapseGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
neuronal cell bodyGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
plasma membraneGlutamate receptor 1Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
intracellular membrane-bounded organelleGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
kainate selective glutamate receptor complexGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
presynaptic membraneGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor 1Homo sapiens (human)
plasma membraneGlutamate receptor 1Homo sapiens (human)
cell-cell junctionGlutamate receptor 1Homo sapiens (human)
cell surfaceGlutamate receptor 1Homo sapiens (human)
ER to Golgi transport vesicle membraneGlutamate receptor 1Homo sapiens (human)
postsynaptic densityGlutamate receptor 1Homo sapiens (human)
dendriteGlutamate receptor 1Homo sapiens (human)
endocytic vesicle membraneGlutamate receptor 1Homo sapiens (human)
synaptic vesicle membraneGlutamate receptor 1Homo sapiens (human)
neuromuscular junctionGlutamate receptor 1Homo sapiens (human)
early endosome membraneGlutamate receptor 1Homo sapiens (human)
dendritic spine membraneGlutamate receptor 1Homo sapiens (human)
neuronal cell body membraneGlutamate receptor 1Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartment membraneGlutamate receptor 1Homo sapiens (human)
neuronal cell bodyGlutamate receptor 1Homo sapiens (human)
dendritic spineGlutamate receptor 1Homo sapiens (human)
dendritic shaftGlutamate receptor 1Homo sapiens (human)
axonal spineGlutamate receptor 1Homo sapiens (human)
neuron spineGlutamate receptor 1Homo sapiens (human)
postsynaptic membraneGlutamate receptor 1Homo sapiens (human)
presynaptic active zone membraneGlutamate receptor 1Homo sapiens (human)
recycling endosomeGlutamate receptor 1Homo sapiens (human)
recycling endosome membraneGlutamate receptor 1Homo sapiens (human)
excitatory synapseGlutamate receptor 1Homo sapiens (human)
synaptic membraneGlutamate receptor 1Homo sapiens (human)
presynapseGlutamate receptor 1Homo sapiens (human)
postsynaptic density membraneGlutamate receptor 1Homo sapiens (human)
glutamatergic synapseGlutamate receptor 1Homo sapiens (human)
postsynaptic density, intracellular componentGlutamate receptor 1Homo sapiens (human)
perisynaptic spaceGlutamate receptor 1Homo sapiens (human)
AMPA glutamate receptor complexGlutamate receptor 1Homo sapiens (human)
plasma membraneGlutamate receptor 1Homo sapiens (human)
dendritic spineGlutamate receptor 1Homo sapiens (human)
postsynaptic density membraneGlutamate receptor 1Homo sapiens (human)
plasma membraneGlutamate receptor 2Homo sapiens (human)
external side of plasma membraneGlutamate receptor 2Homo sapiens (human)
postsynaptic densityGlutamate receptor 2Homo sapiens (human)
dendriteGlutamate receptor 2Homo sapiens (human)
endocytic vesicle membraneGlutamate receptor 2Homo sapiens (human)
asymmetric synapseGlutamate receptor 2Homo sapiens (human)
neuronal cell bodyGlutamate receptor 2Homo sapiens (human)
dendritic spineGlutamate receptor 2Homo sapiens (human)
excitatory synapseGlutamate receptor 2Homo sapiens (human)
postsynapseGlutamate receptor 2Homo sapiens (human)
postsynaptic endocytic zoneGlutamate receptor 2Homo sapiens (human)
AMPA glutamate receptor complexGlutamate receptor 2Homo sapiens (human)
plasma membraneGlutamate receptor 2Homo sapiens (human)
dendritic spineGlutamate receptor 2Homo sapiens (human)
postsynaptic density membraneGlutamate receptor 2Homo sapiens (human)
plasma membraneGlutamate receptor 3Homo sapiens (human)
endocytic vesicle membraneGlutamate receptor 3Homo sapiens (human)
postsynaptic membraneGlutamate receptor 3Homo sapiens (human)
parallel fiber to Purkinje cell synapseGlutamate receptor 3Homo sapiens (human)
AMPA glutamate receptor complexGlutamate receptor 3Homo sapiens (human)
plasma membraneGlutamate receptor 3Homo sapiens (human)
postsynaptic density membraneGlutamate receptor 3Homo sapiens (human)
dendritic spineGlutamate receptor 3Homo sapiens (human)
plasma membraneGlutamate receptor 4Homo sapiens (human)
dendriteGlutamate receptor 4Homo sapiens (human)
endocytic vesicle membraneGlutamate receptor 4Homo sapiens (human)
neuronal cell bodyGlutamate receptor 4Homo sapiens (human)
dendritic spineGlutamate receptor 4Homo sapiens (human)
extracellular vesicleGlutamate receptor 4Homo sapiens (human)
AMPA glutamate receptor complexGlutamate receptor 4Homo sapiens (human)
postsynaptic density membraneGlutamate receptor 4Homo sapiens (human)
plasma membraneGlutamate receptor 4Homo sapiens (human)
dendritic spineGlutamate receptor 4Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)
cytoplasmGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
synaptic vesicleGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
cell surfaceGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
postsynaptic densityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
dendriteGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
neuron projectionGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
synaptic cleftGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
terminal boutonGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
dendritic spineGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
synapseGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
postsynaptic membraneGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
excitatory synapseGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
synaptic membraneGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
synapseGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
neuron projectionGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
synaptic vesicleGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
cell surfaceGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
postsynaptic densityGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
cytoplasmic vesicle membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
presynaptic membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
dendritic spineGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
postsynaptic membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
synaptic membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
glutamatergic synapseGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
dendrite cytoplasmGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
terminal boutonGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
perikaryonGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
mossy fiber rosetteGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
glutamatergic synapseGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
kainate selective glutamate receptor complexGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
presynaptic membraneGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
axonGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
dendriteGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
dendrite cytoplasmGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
terminal boutonGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
perikaryonGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
glutamatergic synapseGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
kainate selective glutamate receptor complexGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
presynaptic membraneGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
cytoplasmGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
lysosomeGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
late endosomeGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
cytoskeletonGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
cell surfaceGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
postsynaptic densityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
neuron projectionGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
postsynaptic membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
synaptic membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
postsynaptic membraneGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
glutamatergic synapseGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
presynaptic membraneGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
kainate selective glutamate receptor complexGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
nucleoplasmGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
endoplasmic reticulumGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
presynaptic membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
kainate selective glutamate receptor complexGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
membraneGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
neuron projectionGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
neuronal cell bodyGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
synapseGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
presynapseGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
glutamatergic synapseGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (89)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID143099Inhibitory activity against NMDA receptor using [3H]-CGS- 19755 as radioligand1993Journal of medicinal chemistry, Jul-09, Volume: 36, Issue:14
(3SR,4aRS,6RS,8aRS)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3 - carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist.
AID144618Antagonism at NMDA receptor by inhibition of depolarizations induced by 40 uM NMDA in rat cortical slice preparation.1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.
AID92372Affinity towards Ionotropic glutamate receptor AMPA using [3H]AMPA as ligand on rat cortical membrane preparations2001Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2
Bioisosteres of 9-carboxymethyl-4-oxo-imidazo[1,2-a]indeno-[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent in vivo AMPA antagonists with longer durations of action.
AID239255Inhibition of [3H]KA binding to human iontropic glutamate receptors 6 and KA-22005Journal of medicinal chemistry, Jun-30, Volume: 48, Issue:13
Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of pain.
AID496860Binding affinity to GluR6 at 10 uM2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID496856Binding affinity to GluR42010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID31732Inhibitory activity against AMPA receptor using [3H]AMPA as radioligand1993Journal of medicinal chemistry, Jul-09, Volume: 36, Issue:14
(3SR,4aRS,6RS,8aRS)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3 - carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist.
AID113366In vivo effective dose required to protect 6 male CD1 mice against tonic convulsions following ip administration for a pretreatment time of 30 min2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Synthesis of anticonvulsive AMPA antagonists: 4-oxo-10-substituted-imidaz.
AID496854Binding affinity to GluR22010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID239233Inhibition of [3H]AMPA binding to human Ionotropic glutamate receptor 22005Journal of medicinal chemistry, Jun-30, Volume: 48, Issue:13
Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of pain.
AID143295Displacement of [3H]DCKA from N-methyl-D-aspartate glutamate receptor of rat cortical membrane2000Bioorganic & medicinal chemistry letters, May-15, Volume: 10, Issue:10
4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with in vivo activity.
AID180285Inhibitory activity against compound induced depolarization of AMPA receptor in rat cortical slice preparation1995Journal of medicinal chemistry, Dec-08, Volume: 38, Issue:25
(3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist.
AID31463Antagonism at AMPA receptor by inhibition of depolarizations induced by 40 uM AMPA in rat cortical slice preparation.1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.
AID73794Displacement of [3H]DCKA from glycine NMDA receptor of rat cortical membranes2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Synthesis of anticonvulsive AMPA antagonists: 4-oxo-10-substituted-imidaz.
AID92210Antagonistic activity against Ionotropic glutamate receptor AMPA using kainate-evoked current in Xenopus oocytes injected with rat brain mRNA2000Bioorganic & medicinal chemistry letters, Dec-18, Volume: 10, Issue:24
Synthesis and potent anticonvulsant activities of 4-oxo-imidazo[1,2-a]inden.
AID239234Inhibition of [3H]KA binding to human iontropic glutamate receptors 5 and 62005Journal of medicinal chemistry, Jun-30, Volume: 48, Issue:13
Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of pain.
AID93256Ability to displace binding of [3H]AMPA to recombinant human Ionotropic glutamate receptor ionotropic kainate 12002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine.
AID1054526Displacement of [3H]ATPA from human Gluk1 receptor2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
GluK1 antagonists from 6-(tetrazolyl)phenyl decahydroisoquinoline derivatives: in vitro profile and in vivo analgesic efficacy.
AID93577Antagonism at Ionotropic glutamate receptor kainate by inhibition of depolarizations induced by 10 uM kainic acid in rat cortical slice preparation.1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.
AID31462AMPA receptor antagonistic activity as inhibition of depolarizations induced by 40 uM AMPA in rat cortical slice preparation1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution.
AID496857Binding affinity to GluR52010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID92211Binding affinity against Ionotropic glutamate receptor AMPA using [3H]AMPA 19755 radioligand1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.
AID113371In vivo effective dose required to protect 6 male CD1 mice against tonic convulsions following iv administration for a pretreatment time of 5 min2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Synthesis of anticonvulsive AMPA antagonists: 4-oxo-10-substituted-imidaz.
AID145164Compound was tested for NMDA receptor antagonistic activity by measuring its ability to inhibit depolarizations induced by 40 uM NMDA in rat cortical slice preparation at 100 uM1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.
AID92370Displacement of [3H]AMPA from Ionotropic glutamate receptor AMPA of rat cortical membranes2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Synthesis of anticonvulsive AMPA antagonists: 4-oxo-10-substituted-imidaz.
AID92961Ability to displace binding of [3H]AMPA to recombinant human Ionotropic glutamate receptor AMPA 22002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine.
AID239192Inhibition of [3H]-KA binding to iontropic glutamate receptor 52005Journal of medicinal chemistry, Jun-30, Volume: 48, Issue:13
Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of pain.
AID496858Binding affinity to GluR62010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID143306Binding affinity for N-methyl-D-aspartate glutamate receptor2000Bioorganic & medicinal chemistry letters, Dec-18, Volume: 10, Issue:24
Synthesis and potent anticonvulsant activities of 4-oxo-imidazo[1,2-a]inden.
AID93101Ability to displace binding of [3H]AMPA to recombinant human Ionotropic glutamate receptor AMPA 32002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine.
AID132057Effective dose of the intraperitoneally administered compound required to protect 50% of mice from tonic convulsion caused by maximal electric shock (MES)2000Bioorganic & medicinal chemistry letters, May-15, Volume: 10, Issue:10
4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with in vivo activity.
AID93110Ability to displace binding of [3H]AMPA to recombinant human Ionotropic glutamate receptor AMPA 42002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine.
AID93576Ionotropic glutamate receptor kainate antagonism by measuring inhibition of 10 uM kainic acid induced depolarizations in rat cortical slice preparation.1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution.
AID496835Displacement of [3H]kainate from kainate receptor in rat cortical membrane2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID92348Binding affinity for Ionotropic glutamate receptor AMPA2000Bioorganic & medicinal chemistry letters, Dec-18, Volume: 10, Issue:24
Synthesis and potent anticonvulsant activities of 4-oxo-imidazo[1,2-a]inden.
AID223446Effective dose to block ATPA-induced muscle rigidity in mice at a dose of 30 mg/kg administered intravenously1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.
AID496859Binding affinity to GluR72010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID93562Binding affinity at Ionotropic glutamate receptor kainate in rat cortical tissue by [3H]-kainic acid displacement.1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution.
AID144599Binding affinity at N-methyl-D-aspartate glutamate receptor in rat cortical tissue by [3H]-CGS- 19755 displacement.1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution.
AID223449Effective dose to block maximal electroshock-induced convulsions in mice, administered intraperitoneally1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.
AID143317Binding affinity against NMDA receptor using [3H]-CGS- 19755 as a radioligand in rat1995Journal of medicinal chemistry, Dec-08, Volume: 38, Issue:25
(3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist.
AID145268In vitro binding affinity towards glycine modulatory site on the NMDA receptors using [3H]DCKA as radioligand in rat cortical membrane preparations1999Bioorganic & medicinal chemistry letters, Oct-18, Volume: 9, Issue:20
Spiro-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives are mixed AMPA and NMDA glycine-site antagonists active in vivo.
AID92509Displacement of [3H]AMPA from Ionotropic glutamate receptor AMPA of rat cortical membranes2000Bioorganic & medicinal chemistry letters, May-15, Volume: 10, Issue:10
4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with in vivo activity.
AID93559Binding affinity against Ionotropic glutamate receptor kainate using [3H]-Kainic acid 19755 radioligand1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.
AID223450Effective dose to produce neurological impairments in mice using the horizontal screen assay, administered intraperitoneally1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.
AID91457Binding affinity against Ionotropic glutamate receptor kainate using [3H]-Kainic acid as a radioligand1995Journal of medicinal chemistry, Dec-08, Volume: 38, Issue:25
(3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist.
AID1054527Displacement of [3H]AMPA from homomeric recombinant GluA2 receptor (unknown origin)2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
GluK1 antagonists from 6-(tetrazolyl)phenyl decahydroisoquinoline derivatives: in vitro profile and in vivo analgesic efficacy.
AID219907Inhibition of currents generated by 50 uM kainate in Xenopus oocytes injected with rat brain mRNA2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Synthesis of anticonvulsive AMPA antagonists: 4-oxo-10-substituted-imidaz.
AID726083Inhibition of GluK1 receptor (unknown origin)2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Ion channels as therapeutic targets: a drug discovery perspective.
AID95026Inhibitory activity against generation of currents by 50 uM kainate in Xenopus oocytes injected with rat brain mRNA2000Bioorganic & medicinal chemistry letters, May-15, Volume: 10, Issue:10
4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with in vivo activity.
AID239193Inhibition of [3H]KA binding to iontropic glutamate receptor 62005Journal of medicinal chemistry, Jun-30, Volume: 48, Issue:13
Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of pain.
AID112514In vivo activity determined by Maximum electroshock induced seizures (MES) assay in mice after ip administration1999Bioorganic & medicinal chemistry letters, Oct-18, Volume: 9, Issue:20
Spiro-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives are mixed AMPA and NMDA glycine-site antagonists active in vivo.
AID92371In vitro binding affinity towards ionotropic glutamate receptor AMPA using [3H]AMPA as radioligand in rat cortical membrane preparations1999Bioorganic & medicinal chemistry letters, Oct-18, Volume: 9, Issue:20
Spiro-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives are mixed AMPA and NMDA glycine-site antagonists active in vivo.
AID92950Ability to displace binding of [3H]AMPA to recombinant human Ionotropic glutamate receptor AMPA 12002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine.
AID496863Neuroprotective activity against middle cerebral artery occlusion-induced focal cerebral ischemia in Mongolian gerbils assessed as reduction in infarct volume in hemesphere2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID180286Inhibitory activity against compound induced depolarization of Kainic acid receptor in rat cortical slice preparation1995Journal of medicinal chemistry, Dec-08, Volume: 38, Issue:25
(3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist.
AID496861Anticonvulsant activity in ip dosed mouse assessed as inhibition of MES-induced tonic seizures2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID496877Toxicity in human assessed as hazy vision2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID496878Toxicity in human assessed as sedation2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID93404Ability to displace binding of [3H]KA to recombinant human KA receptor Ionotropic glutamate receptor ionotropic kainate 2 expressed in EK 293 cell membranes2002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine.
AID496876Toxicity in human assessed as occurance of systemic allodynia2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID144617Compound was tested for NMDA receptor antagonistic activity by measuring its ability to inhibit depolarizations induced by 40 uM NMDA in rat cortical slice preparation.1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution.
AID92801Binding affinity against Ionotropic glutamate receptor AMPA using [3H]AMPA as a radioligand1995Journal of medicinal chemistry, Dec-08, Volume: 38, Issue:25
(3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist.
AID132056Effective dose of the intraperitoneally administered compound required to protect 50% of DBA/2 mice from tonico-clonic convulsion; Not tested2000Bioorganic & medicinal chemistry letters, May-15, Volume: 10, Issue:10
4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with in vivo activity.
AID93728Compound was tested for Ionotropic glutamate receptor kainate antagonistic activity by measuring its ability to inhibit depolarizations induced by 10 uM kainic acid in rat cortical slice preparation.1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.
AID93410Ability to displace binding of [3H]AMPA to recombinant human AMPA receptor Ionotropic glutamate receptor ionotropic kainate 32002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine.
AID496855Binding affinity to GluR32010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID496834Displacement of [3H]AMPA from AMPA receptor in rat cortical membrane2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID92346Binding affinity at Ionotropic glutamate receptor AMPA in rat cortical tissue by [3H]AMPA displacement.1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution.
AID496864Neuroprotective activity against middle cerebral artery occlusion-induced focal cerebral ischemia in cat assessed as reduction in infarct volume in hemesphere2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID496853Binding affinity to GluR12010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID726082Inhibition of AMPA receptor (unknown origin)2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Ion channels as therapeutic targets: a drug discovery perspective.
AID180288Inhibitory activity against compound induced depolarization of NMDA receptor in rat cortical slice preparation1995Journal of medicinal chemistry, Dec-08, Volume: 38, Issue:25
(3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist.
AID239254Inhibition of [3H]KA binding to human iontropic glutamate receptors 5 and KA-22005Journal of medicinal chemistry, Jun-30, Volume: 48, Issue:13
Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of pain.
AID144469Affinity of [3H]-CGS- 19755 radioligand to rat N-methyl-D-aspartate (NMDA) receptor1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.
AID496862Neuroprotective activity against middle cerebral artery occlusion-induced focal cerebral ischemia in Mongolian gerbils assessed as reduction in infarct volume in cortex2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID144764In vitro binding affinity towards NMDA glutamate receptor using [3H]5,7-dichlorokynurenate as ligand on rat cortical membrane preparations2001Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2
Bioisosteres of 9-carboxymethyl-4-oxo-imidazo[1,2-a]indeno-[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent in vivo AMPA antagonists with longer durations of action.
AID113961Anticonvulsant activity in male CD1 mice2000Bioorganic & medicinal chemistry letters, Dec-18, Volume: 10, Issue:24
Synthesis and potent anticonvulsant activities of 4-oxo-imidazo[1,2-a]inden.
AID93403Ability to displace binding of [3H]AMPA to recombinant human AMPA receptor Ionotropic glutamate receptor ionotropic kainate 22002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine.
AID223296Dose which protected 50 % of the mice from a tonic convulsion.2001Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2
Bioisosteres of 9-carboxymethyl-4-oxo-imidazo[1,2-a]indeno-[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent in vivo AMPA antagonists with longer durations of action.
AID496865Neuroprotective activity against middle cerebral artery occlusion-induced focal cerebral ischemia in cat assessed as reduction in infarct volume in cortex2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID223293Dose which protected 50 % of the mice from a tonic convulsion.2001Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2
Bioisosteres of 9-carboxymethyl-4-oxo-imidazo[1,2-a]indeno-[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent in vivo AMPA antagonists with longer durations of action.
AID496836Inhibition of NMDA receptor glutamate site from rat cortical membrane2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
AID1054524Analgesic activity in rat assessed as reversal of carrageenan-induced thermal hyperalgesia at 10 mg/kg, sc after 30 to 40 mins relative to vehicle-treated control2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
GluK1 antagonists from 6-(tetrazolyl)phenyl decahydroisoquinoline derivatives: in vitro profile and in vivo analgesic efficacy.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (100)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's43 (43.00)18.2507
2000's36 (36.00)29.6817
2010's16 (16.00)24.3611
2020's5 (5.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.65 (24.57)
Research Supply Index4.68 (2.92)
Research Growth Index4.33 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (3.88%)5.53%
Reviews4 (3.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other95 (92.23%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]